LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,527
تعداد دریافت فایل اصل مقاله11,291,331
Foroutan, Hamid Reza, Hosseini, A.H., Dehghani, S.M., Banani, S.A., Bahador, A., Haghighat, M., Imanieh, M.H., Jalli, R., Gheisari, F.. (1387). Peri-Operative High-Dose v Post-Operative Low Dose Steroid Therapy in the Management of Biliary Atresia: a Preliminary Report. سامانه مدیریت نشریات علمی, 33(2), 79-83.
Hamid Reza Foroutan; A.H. Hosseini; S.M. Dehghani; S.A. Banani; A. Bahador; M. Haghighat; M.H. Imanieh; R. Jalli; F. Gheisari. "Peri-Operative High-Dose v Post-Operative Low Dose Steroid Therapy in the Management of Biliary Atresia: a Preliminary Report". سامانه مدیریت نشریات علمی, 33, 2, 1387, 79-83.
Foroutan, Hamid Reza, Hosseini, A.H., Dehghani, S.M., Banani, S.A., Bahador, A., Haghighat, M., Imanieh, M.H., Jalli, R., Gheisari, F.. (1387). 'Peri-Operative High-Dose v Post-Operative Low Dose Steroid Therapy in the Management of Biliary Atresia: a Preliminary Report', سامانه مدیریت نشریات علمی, 33(2), pp. 79-83.
Foroutan, Hamid Reza, Hosseini, A.H., Dehghani, S.M., Banani, S.A., Bahador, A., Haghighat, M., Imanieh, M.H., Jalli, R., Gheisari, F.. Peri-Operative High-Dose v Post-Operative Low Dose Steroid Therapy in the Management of Biliary Atresia: a Preliminary Report. سامانه مدیریت نشریات علمی, 1387; 33(2): 79-83.

Peri-Operative High-Dose v Post-Operative Low Dose Steroid Therapy in the Management of Biliary Atresia: a Preliminary Report

Iranian Journal of Medical Sciences
مقاله 3، دوره 33، شماره 2، شهریور 2008، صفحه 79-83    اصل مقاله (56.55 K)
نوع مقاله: Original Article(s)
نویسندگان
Hamid Reza Foroutan* ؛ A.H. Hosseini؛ S.M. Dehghani؛ S.A. Banani؛ A. Bahador؛ M. Haghighat؛ M.H. Imanieh؛ R. Jalli؛ F. Gheisari
چکیده
Background: The use of high-dose steroid therapy peri portoenterostomy may have a positive impact on the frequency of cholangitis and survival rate. Methods: A prospective study was conducted on two groups of patients (less than three months of age) suffering from biliary atresia from 1999 to 2005. The patients in group I (G I) were managed peri-operatively by high-dose methylprednisolone while the other group (G II) received low dose methylprednisolone only post-operatively (2mg/k/day for 1 month). Infants in GI (n=30) received methylprednisolone for 3 successive days before operation (10-8-6mg/kg/day), and 10 mg/k at the day of operation respectively. Thereafter the dose was tapered in the next successive 6 days by 8, 6, 5, 4, 3, and 2 mg/kg/day and continued for one month. Results: Seventy two infants with biliary atresia were operated (39 girls and 33 boys). Twenty-six of the 30 patients (86%) in G I became jaundice-free within 90 days after portoenterostomy while only seven (15%) of the 42 patients in G II had normal bilirubin (p <0.0001). Episodes of postoperative cholangitis in G I were 20% (6 of 30), and 53% (24 of 42) in G II (p <0.005). The difference in 3-year survival rate between the two groups is also remarkable: Eighty seven percent (26 of 30) in GI versus 29% (13 of 45) in G II (p <0.005). Death related to biliary atresia occurred in 1 (3.3%) patient in GI compared with 12 (29%) patients in G II (p <0.005). Conclusion: These results provide strong evidence that peri-operative high dose steroid therapy is not only safe in this patients population, but because of its anti-inflammatory and cholerrhetic effects has a positive impact on preventing recurrent cholangitis, and ultimately survival.
کلیدواژه‌ها
Biliary atresia؛ cholangitis؛ steroid
آمار
تعداد مشاهده مقاله: 2,613
تعداد دریافت فایل اصل مقاله: 1,213


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب